|Bid||0.05 x 1100|
|Ask||16.00 x 4000|
|Day's Range||11.80 - 12.05|
|52 Week Range||10.44 - 25.55|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The biotech sector was in focus last week with Protagonist's stock plunging on news of discontinuation of a phase IIb study and Verona Pharma stock surging on positive top-line data from COPD study among others.
Verona Pharma plc (AIM:VRP), a pharmaceuticals company based in United Kingdom, saw a double-digit share price rise of over 10% in the past couple of months on the AIM. WithRead More...
For Verona Pharma plc’s (AIM:VRP) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. Generally, an investorRead More...